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1  | INTRODUC TION
Ischemic stroke occurs when the blood supply to part of the brain is 
interrupted due to obstruction of a vessel by an embolism or throm-
bus. Current treatments need to be applied shortly after the onset 
of stroke, which is not always possible.1 Therefore, there is a need 
for additional treatment and prevention strategies that are more 
broadly applicable.
Several risk factors for stroke are potentially modifiable, includ-
ing cigarette smoking, alcohol consumption, obesity, lack of phys-
ical activity and an unhealthy diet.2,3 Diet may play an important 
role in the prevention of stroke. For example, high consumption of 
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mation. Evidence suggests that food components may exert anti- inflammatory prop-
erties and thus may reduce stroke- induced brain damage.
Aim: To investigate the efficacy of a diet, containing anti- inflammatory ingredients, 
as treatment for focal ischemic brain damage induced by photothrombotic stroke in 
the somatosensory cortex of rats.
Results: Brain lesions were surrounded by strong astrogliosis on both day 7 and day 
21 after stroke and were accompanied by a trend toward globally decreased glucose 
metabolism on day 7. The investigational diet applied 2 weeks before the ischemia 
did not affect astrocyte activation on day 7, but reduced it at day 21. The investiga-
tional diet applied immediately after the ischemia, increased astrocyte activation on 
day 7 and completely reversed this effect on day 21. Moreover, postischemic 
 intervention increased glucose metabolism in somatosensory cortex ipsilateral to the 
lesion on day 7.
Conclusion: This study reveals potentially beneficial effects of a diet containing ele-
vated amounts of anti- inflammatory nutrients on the recovery from ischemic brain 
damage. Therefore, dietary intervention can be considered as an adjuvant therapy 
for recovery from this brain pathology.
K E Y W O R D S
neuroinflammation, nutrition, PET imaging, photothrombotic stroke
2  |     KURTYS eT al.
fruit, vegetables, olive oil and fish is associated with a lower inci-
dence of stroke4 and can reduce its risk. Therefore, a proper diet 
could be a lifestyle intervention to prevent stroke or ameliorate its 
consequences.5
Many food components with potential preventive effects for 
stroke onset in humans, such as omega- 3 fatty acids, vitamins and 
fibers, have anti- inflammatory properties.6-10 Indirect evidence 
suggests a positive impact of anti- inflammatory diet on the survival 
following stroke in humans.11 Preclinical studies demonstrated a 
positive effect of anti- inflammatory food components on neuro-
protection.12,13 It is known that stroke can trigger an inflammatory 
response and cause neuronal death.14 The inflammatory response 
is characterized by the activation and increased proliferation of mi-
croglia and astrocytes that produce inflammatory mediators. This 
process has an ambivalent role as it has been shown to be involved 
in both neurotoxicity and neuroprotection.15 It is currently believed 
that early neuroinflammatory response has beneficial effect by lim-
iting tissue damage and promoting repair, but chronic and persistent 
neuroinflammation can lead to cell dystrophy and promote neuro-
degeneration.16 Since inflammation is under investigation as one of 
the potential targets for new therapeutic approaches in stroke,17,18 
we hypothesized that anti- inflammatory food components may have 
a preventive and possibly a therapeutic effect on stroke and could 
possibly be considered for future adjuvant therapy.
The aim of this study was to investigate whether a diet contain-
ing elevated amounts of anti- inflammatory nutrients can have ben-
eficial effects on the recovery from stroke.19 The photothrombotic 
stroke model was selected for this proof- of- concept study, because 
it is minimally invasive and relatively moderate. The inflammatory 
response caused by the stroke is expected to be relatively mild, and 
therefore, ceiling effects that may obscure the effects of dietary 
intervention are less likely to occur. The investigational diet in this 
study was based on results from our20 and other studies6,10,21,22 
and was designed to maximize the effect by combining the anti- 
inflammatory properties of its components. The dietary intervention 
was started either 2 weeks before, or directly after the induction 
of ischemia. We monitored astrocyte activation at day 7 and 21 
following ischemia, since activated astrocytes are believed to play 
a protective role at the early stages of stroke,23 but may become 
detrimental if the activation persists. We also studied brain glucose 
metabolism as a functional parameter, using positron emission to-
mography (PET) with the glucose analogue [18F]FDG. This technique 
has already been successfully used to noninvasively monitor stroke 
progression in animals24 and in humans.25 Moreover, we investigated 
the effect of the diet on motor dysfunction with the cylinder test.26
2  | MATERIAL S AND METHODS
2.1 | Experimental animals
Animal	 experiments	 were	 approved	 by	 the	 Institutional	 Animal	
Care and Use Committee of the University of Groningen (protocol 
DEC6971A)	 and	performed	 in	 accordance	with	Dutch	Regulations	
for	Animal	Welfare.
Male outbred Sprague Dawley rats (10 weeks of age, n = 48, 
302 ± 3 g) were purchased from Harlan (Horst, The Netherlands) 
and housed in groups (2- 6 animals per cage) in thermo- regulated 
(21 ± 2°C) and humidity- controlled rooms under a 12- 12- hour light- 
dark cycle (lights on at 6 am). Food and water were available ad libi-
tum, and paper rolls were used as cage enrichment. The rats were 
allowed	to	acclimatize	for	at	least	7	days	after	arrival.	All	rats	were	
fed	with	a	standard	laboratory	chow	(AIN93-	G)	from	the	time	of	ar-
rival until the start of the experiment.27 Rats were housed individu-
ally after surgery until the end of the experiment.
2.2 | Diet
Two iso- caloric diets were used in the study: a control diet 
(AIN93-	G)	and	an	investigational	diet	based	on	AIN93-	G	(Research	
Diet	 Services,	Wijk	 bij	Duurstede,	 The	Netherlands).	 As	 shown	 in	
Table 1, the investigational diet contains low- glycemic index carbo-





Experimental procedures and data analysis were performed accord-
ing to RIGOR criteria recommended for translational research.28 
Rats were randomly divided into 8 groups (n = 6 per group, Figure 1). 
Photothrombotic stroke and sham- surgeries were performed on ex-
perimental day 0, rats were sacrificed on day 7 (CC7, SC7, SI- pre7, 
SI- post7) or day 21 (CC21, SC21, SI- pre21, SI- post21). Six groups were 
subjected to the induction of focal cortical ischemia and to one of 
3 different feeding protocols: Stroke control groups (SC7 and SC21) 
were fed with control diet during the entire experiment; The pre-
ventive stroke intervention groups (SI- pre7 and SI- pre21) were fed 
with the investigational diet starting from 2 weeks before ischemia 
(day- 14); The poststroke intervention groups (SI- post7 and SI- post21) 
were fed with the investigational diet starting from the day of the 
ischemia induction (day 0). The sham control groups (CC7 and CC21) 
were subjected to sham- surgery and fed with the control diet during 
the entire experiment.
Animals	were	weighted	daily.	Motor	dysfunction	was	assessed	
with the cylinder test 8 days before surgery (baseline) and 3, 6 and 
20 days after ischemia. [18F]FDG PET imaging was performed 7 days 
before the ischemia induction or sham- surgery (baseline) and either 
7 or and 21 days after the ischemia. The animals were terminated 
after last scan for tissue collection.
Due to complications with anesthesia, 2 rats did not survive the 
surgery on day 0 (from the CC21 group), and 2 rats did not survive the 
[18F]FDG PET scan on day 21 (from the SC21 and SI- post21 groups). 
Thus, 4 animals were excluded from the study.
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2.4 | Stroke induction and sham- surgery
Focal ischemic cortical lesions were induced by photothrombotic 
stroke as described previously.19 Briefly, rats were anesthetized with 
a mixture of ketamine (Ketalar®, 60 mg/kg; Pfizer, Brussels, Belgium) 
and medetomidine (Domitor®, 0.4 mg/kg intraperitoneal; Brussels, 
Belgium, Pfizer). The body temperature of the animals was main-
tained with heating pads; eye salve was applied onto the eyes to 
prevent dehydration. Before surgery, 100 μL	of	xylocaine	with	2%	
adrenaline was applied on the skin as a local anesthetic and to reduce 
bleeding.	The	skull	was	exposed	by	a	lateral	incision	of	the	skin.	After	
intravenous injection of the photosensitizer Rose Bengal (20 mg/kg; 
Sigma-	Aldrich,	 St.	 Louis,	MO),	 an	 area	 of	 the	 exposed	 intact	 skull	
was irradiated for 20 minutes with green light (wavelength 540 nm, 
bandwidth	80	nm)	 from	a	xenon	 lamp	 (model	 L-	4887;	Hamamatsu	
Photonics, Hamamatsu City, Japan) with heat- absorbing green fil-
ters. The radiation with an intensity of 0.68 W/cm2 was directed 
with a 3- mm optical fiber placed on the skull above the right so-
matosensory	cortex	next	to	Bregma.	Light-	induced	oxidation	of	the	
photosensitizer causes endothelial damage, platelet activation and 
consequently vascular occlusion.29	At	the	end	of	surgery,	anesthesia	
was	 reversed	 with	 atipamezole	 (Antisedan®, 1 mg/kg intraperito-
neal; Orion Pharma, Newbury, UK). Finadyne (1 mg/kg) was given 
prior to and 24 hour after surgery to reduce pain. For sham- surgery, 
the same procedure was performed, except for the application of 
radiation	on	the	skull.	Afterward,	rats	were	housed	individually	until	
the end of the experiment.
2.5 | Cylinder test
The cylinder test was used to quantify asymmetric forelimb use.26 
Rats were placed in a 20- cm- wide clear glass cylinder located in front 
of 2 mirrors to facilitate the observation of the behavior from each 
side.	A	total	of	20	contacts	with	the	cylinder	wall	by	either	forepaw	
were scored from the video by an independent observer, who was 
blinded to the treatment of the animals. The number of contralateral 
forelimb (left forelimb) contacts was expressed as a percentage of 
total	forelimb	contacts.	Normal	rats	should	score	50%	in	this	test.30 
The test was performed in light phase and recorded on video.
2.6 | PET imaging
[18F]FDG PET scans were performed using a dedicated small animal 
PET	scanner	(Focus	220,	Siemens	Medical	Solutions	USA,	Malvern,	
PA).	The	body	 temperature	of	 the	 rats	was	maintained	with	heat-
ing pads, eye salve was applied onto the eyes to prevent dehydra-
tion, and heart rate and blood oxygen levels were monitored with a 
BioVet system (M2M Imaging, Cleveland, OH). Two rats from differ-
ent experimental groups were scanned simultaneously in each scan-
ning session.
The rats were anesthetized with isoflurane mixed with oxygen 
(5%	 induction	and	2%	maintenance,	0.8	L/min),	and	a	cannula	was	
inserted into the tail vein for tracer injection. Before each PET ac-
quisition, a transmission scan of 10 minutes with a 57Co point source 
was performed and used to correct for attenuation, scatter and ran-
dom coincidences. Next, 18 ± 7 MBq [18F]FDG was injected with a 
pump for 1 minutes and immediately a 60- minutes PET scan was 
started. There were no statistically significant differences in the in-
jected tracer dose between the groups (F(7, 39) = 0.208, P = 0.98). 
TABLE  1 The composition of the investigational diet
Investigational diet components compared 
to control diet (per kg diet) Supplier
Carbohydrates
Dextrinized corn starch and sucrose substituted by:
41.5	wt%	maltodextrin	(DE6) Roquette	(Lestrem,	
France)
15.0	wt%	free	galactose Inalco (Milan, Italy)








2%	rice	fiber	RemyLiVe200 Beneo Orafti 
(Oreye, Belgium)







1:1	soy	protein	isolate	770LN Solae company (St. 
Louis,	MO,	USA)








27.5 g Nissui anchovy oil Nippon Suisan 
Kaisha (Tokyo, 
Japan)
6.5	g	Biopure	DHA	IF	tuna	oil Bioriginal (Den 
Bommel, The 
Netherlands)





B6, B12, D2, folic acid




2.7 | PET image reconstruction and analysis
List-	mode	data	 from	the	60-	minutes	 [18F]FDG emission scan were 
reconstructed into 3 frames (2400 seconds, 2 x 600 seconds). 
Emission sinograms were normalized and corrected for attenua-
tion and decay of radioactivity and iteratively reconstructed using 
OSEM2D (4 iterations and 16 subsets).31 PET data were not cor-
rected for blood glucose levels, because previous reports indicate 
that glucose correction does not improve the inter- subject variabil-
ity32 and it may even introduce more noise.33
A	10-	minutes	frame	of	the	[18F]FDG PET scan, starting 50 min-
utes post injection, was used to explore the differences in brain 
glucose metabolism between the groups. The images were auto-
matically coregistered with a tracer- specific template,34 using Vinci 
4.26 software (Max Planck Institute for Neurological Research, 
Cologne, Germany). Standardized uptake values (SUV) of the tracer 
in the brain were calculated according to the following equation: 
SUV	=	[tissue	 activity	 concentration	 [(MBq/mL)	x	bodyweight	 (g)]/
[injected	dose	(MBq)	x	brain	tissue	density	(g/mL)].	It	is	assumed	that	
the	brain	tissue	density	is	1	g/mL.	The	data	were	analyzed	using	the	













were washed 3 times with PBS and the secondary antibody, anti-
mouse	Cy3	(Life	Technologies)	in	a	1:1000	dilution	in	PBS	containing	
1%	BSA,	was	applied	for	1	hour.	The	sections	were	washed	3	times	
with PBS, and the slides were covered with quick- hardening mount-
ing medium (Eukitt®,	 Sigma-	Aldrich)	 and	 a	 microscope	 coverslip.	
F IGURE  1 Study design. Eight experimental groups with 3 different dietary regimens were subjected to focal cortical ischemia or sham- 
surgery at experimental day 0 and sacrificed on day 7 (CC7, SC7, SI- post7, SI- pre7) or day 21 (CC21, SC21, SI- post21, SI- pre21). The stroke 
control groups (SC7 and SC21) were fed with the control diet for the whole experiment; the stroke groups receiving preischemic treatment 
with the investigational diet (SI- post7 and SI- pre21) were fed with the investigational diet from the day of the ischemia (day 0) until the end of 
the experiment (day 7 or day 21, respectively); and the stroke groups receiving preischemic treatment with the investigational diet (SI- pre7 
and SI- pre21) were fed with the investigational diet from 2 weeks before ischemia (day 14) until the end of the experiment (day 7 or day 
21, respectively). The control groups (CC7 and CC21) were subjected to sham- surgery at day 0 and fed with the control diet for the whole 
experiment. Behavioral tests were performed 8 days before (day 8, baseline) and 3, 6 and 21 days after ischemia or sham- surgery. Positron 
emission tomography (PET) scans were performed 7 days before (day 7, baseline) stroke induction or sham- surgery and on day 7 (groups 
CC7, SC7, SI- post7 and SI- pre7) or 21 (groups CC21, SC21, SI- post21 and SI- pre21) after stroke or sham- surgery
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Digital images from areas of interest on the sections (identified 
based on a stereotaxic atlas35)	 were	 acquired	 with	 a	 TissueFAXS	
system (Tissue Gnostics).
The images were scored by an independent observer, who was 
blinded	to	the	treatment	of	the	animals.	Expression	of	GFAP-	stained	
cells was determined in randomly selected 0.0432 mm2 sections of 
3-	5	brain	slices	per	rat	using	ImageJ	software	(NIH,	USA).	The	area	
surrounding the infarct (located 350 μm and 700 μm from the lesion) 
and the contralateral side were analyzed by integrated density to 
assess the surface covered by the staining.
2.9 | Statistical analysis
Statistical analysis of bodyweight, behavior and immunohis-
tochemistry data was performed using IBM SPSS software 
Statistics 22 (SPSS Inc., United States). Results are presented as 
mean ± standard error of the mean (SEM). Differences in body-
weight between groups at the start of the experiment were 
analyzed	by	one-	way	ANOVA.	Bodyweight	changes	following	is-
chemia induction or sham- surgery were analyzed for differences 
between time points and between groups with the generalized 
estimating equations (GEE) model with a Bonferroni post hoc cor-
rection to account for multiple comparisons.36,37 The exchange-
able correlation matrix and the Wald test were used to calculate 
P- values. Results from the behavioral test, immunohistochem-
istry and [18F]FDG	 SUV	 were	 analyzed	 with	 one-	way	 ANOVA	
followed by Bonferroni post hoc correction to account for mul-
tiple comparisons, unless stated otherwise in the results section. 
Differences in lesion size changes between groups were analyzed 
with an unpaired t- test. Differences were considered statistically 
significant when P < 0.05.
3  | RESULTS
3.1 | Bodyweight
Results are summarized in Table 2. The average bodyweight on day 
0, before ischemia induction or sham- surgery, was not statistically 
different between groups (F(3) = 2.000, P = 0.112, Figure 2). The 
SI- post21 group had a significantly lower bodyweight than all other 
groups (CC21, SC21, SI- pre21; P < 0.05) at all time points between 
stroke induction and termination (day 1- day 21).
3.2 | Infarct size
At	day	7	 and	21	 after	 ischemia	 induction,	 the	 infarct	 size	was	 as-
sessed on the isolated brains by measuring the maximum length and 
width (alongside and perpendicular to Bregma, respectively) of the 
visible scar. No significant differences between the groups subjected 
to focal ischemia were observed on day 7 (F(2) = 0.043, P = 0.958) or 
21 (F(2) = 1.006, P	=	0.39,	Figure	3).	Although	the	scar	was	substan-
tially	 smaller	 (−35%)	 in	 the	 SI-	post21 group, statistical significance 
was not reached due to the large between- subject variation in initial 
lesion size (SC21: 5.8 ± 0.7 mm
2 vs SI- post21: 3.8 ± 0.2 mm, P = 0.31; 
SC21 vs SI- pre21: 6.3 ± 0.5 mm, P = 0.83).
3.3 | Cylinder test
Baseline measurements before surgery (day 8) did not reveal any 
preference for the left or right paw, and consequently, no significant 
differences between groups (F(3) = 0.085, P = 0.97, Figure 4) were 
observed. The cylinder tests on day 3 post surgery demonstrated 
a significantly reduced use of the paw contralateral to the lesion 
(F(3) = 8.746, CC7	 60.8	±	2.7%,	 SC7	 35.0	±	4.1%,	 P < 0.01). Only a 
trend toward asymmetric forepaw use was still observed on day 6 
(F(3) = 2.606, P = 0.067), whereas no asymmetry was observed any-
more on day 20 (F(3) = 0.303, P = 0.82).
The investigational diet did not reverse the stroke- induce asym-
metric paw use on day 3 (SC7	35.0	±	4.1%,	SI-	post7	35.0	±	5.3%,	SI-	
pre 32.5 ± 5.4).
3.4 | Astrocyte expression
Glial fibrillary acidic protein staining demonstrated significant dif-
ferences between the groups in astrocyte expression close to the 
lesion site (350 μm, F(3) = 30.84, P	<	0.0001,	Figure	5A	and	B),	with	
a	significant	 increase	in	GFAP	staining	following	ischemia,	both	on	
day 7 (SC7 2.5 ± 0.13, CC7 1.0 ± 0.17, P < 0.001) and on day 21 (SC21 
1.94 ± 0.20, CC21 1.00 ± 0.08, P < 0.0001). Further away from the 
lesion site (700 μm),	no	significant	effect	of	ischemia	on	GFAP	stain-
ing	was	observed	(Figure	6A	and	B).
At	day	7,	the	investigational	diet	did	not	have	a	significant	effect	
on the ischemia- induced expression of astrocytes close to the lesion 
site (SI- pre7: 3.03 ± 0.13, P = 0.39 and SI- post7: 2.07 ± 0.23, vs SC7 
P = 0.06). On day 21, the postischemic dietary intervention had com-
pletely	reversed	the	effect	of	 ischemia	on	GFAP	staining	(SI-	post21: 
0.97 ± 0.04, SI- post21 vs SC21 P < 0.0001, SI- post21 vs CC21 P = 0.86). 
The preischemic dietary intervention caused partial reversal of as-
trocyte activation on day 21 (SI- pre21: 1.54 ± 0.06, SI- pre21 vs SC21 
P < 0.05, SI- pre21 vs CC21 P < 0.05, SI- post21 vs SI- pre21: P < 0.05).
3.5 | Brain metabolism
[18F]FDG PET imaging demonstrated a trend toward a reduction in 
whole brain metabolism due to ischemia on day 7 (CC7 = 1.47 ± 0.02 
vs SC7 = 1.31 ± 0.02, P = 0.06, Figure 6), but not anymore on day 21 
(CC21 = 1.47 ± 0.05 vs SC21 = 1.5 ± 0.05, P = 0.88). In the somatosen-
sory cortex, a trend toward lower glucose metabolism due to stroke 
was observed on day 7 (CC7 = 1.22 ± 0.02 vs SC7 = 1.03 ± 0.03, 
P = 0.08, Figure 6)
The whole brain glucose metabolism was not affected by the 
dietary intervention (SI- post7 = 1.3 ± 0.03, SI- pre7 = 1.46 ± 0.02; 
SC7 vs SI- post7, P = 0.99; SC7 vs SI- pre7, P = 0.19). The somatosen-
sory cortex ipsilateral to the lesion revealed a significant increase 
in metabolism due to the dietary intervention (SC7 = 1.03 ± 0.03 vs 
SI- pre7 = 1.3 ± 0.02; SC7 vs SI- pre7, P = 0.02).
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The diet by itself did not influence global brain glucose metab-
olism as shown by comparison of the baseline scans (day 7) of the 
SI- pre groups vs the other groups (t- test, P = 0.35, supplementary 
Figure 2).
4  | DISCUSSION
Despite epidemiological,4,11,38-42 clinical43,44 and preclinical45 evi-
dence that food can contribute to the prevention of stroke and 
have a positive impact on survival of stroke patients, many ques-
tions around the impact of diets on recovery after stroke remain 
unanswered. The aim of this study was to assess the potential of 
an anti- inflammatory dietary intervention to modulate the effects 
of cortical ischemia in a rat model of photothrombotic stroke. We 
demonstrated that anti- inflammatory diet intervention can affect 
astrocyte activation and brain glucose metabolism following is-
chemic damage.
Photothrombotic stroke is a minimally invasive, reproduc-
ible method to create a chemically induced cortical lesion.46 The 
severity of the model is relatively low and can be modulated by 
changing the duration of irradiation. Both induction of ischemia 
and	 sham-	surgery	 temporarily	 caused	 up	 to	 10%	 decrease	 in	
bodyweight. This suggests that not the ischemic lesion itself, but 
the whole surgical procedure caused a transient decrease in body-
weight. This effect could be ascribed to a reduction in food intake 
during and early after surgery (supplementary Figure 1). The fact 
that ischemia did not cause any further decrease in body weight 
agrees with the low severity of this stroke model.
Cylinder test data demonstrated that introduction of ischemia, 
but not sham- surgery, led to transient lateral motor dysfunction, 
which was observed on day 3 after ischemia induction and was 
normalized again from day 6 onwards, indicating low severity of 
the model. This is consistent with previous studies demonstrat-
ing lateral motor dysfunction shortly after ischemia26 and sug-
gests that the function of the affected area was quickly restored, 
possibly as a result of compensation by other brain regions. More 
persistent effects in brain were detected with [18F]FDG PET and 
GFAP	staining.
To gain more insight in the effects of stroke on brain function, 
we applied [18F]FDG PET imaging to investigate the effect of corti-
cal ischemia on brain metabolism. The global brain metabolism was 
Parameter
The effects of 
ischemia
The effects of the investigational 
diet
SC vs CC SI- pre vs SC SI- post vs SC
Bodyweight (day 1- day 21) ≅ ≅ ↓












Whole brain, day 7 ≅ ≅ ≅
Ipsilateral glucose metabolism 
(somatosensory cortex), day 7
≅ ↑ ≅
The table presents the main effects of ischemia and investigational diet on bodyweight, early motor 
function (on day 3), astrocyte expression close to the lesion (300 μm), glucose metabolism on day 7. 
Motor	 function	 on	 later	 time	 points	 (day	 6,	 21),	 Glial	 fibrillary	 acidic	 protein	 (GFAP)	 expression	
700 μm from the lesion, glucose metabolism on day 21 are not included, since little effect on these 
parameters was observed.
TABLE  2 The main effects of ischemia 
and its modulation by the investigational 
diet
F IGURE  2 Changes in body weight in animals sacrificed 
on day 21 after ischemia induction or sham- surgery: body 
weight is displayed as percentage of the body weight on 
the day of ischemia induction or sham- surgery (day 0). 
CC21 = control group (n = 4), SC21 = stroke + control diet (n = 5), 
SI- post21 = stroke + postischemic dietary intervention (n = 5), 
SI- pre21 = stroke + preischemic dietary intervention (n = 6). The 
body weight of the stroke group treated with the investigational 
diet after stroke induction (SI- post21) was significantly lower than 
all the other groups (CC21, SC21, SI- pre21) at all time points after 
stroke induction (day 1- day 21). No significant differences between 
the CC21, SC21 and SI- pre21 groups were observed. *P < 0.05 for SI- 
post21, when compared to CC21, SC21, SI- pre21 (GEE model)
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not significantly affected by the cortical damage, indicating a low 
severity of the model. PET imaging at either day 7 or day 21 did not 
detect hypometabolic lesion at the location of the photothrombotic 
stroke.	A	 trend	 toward	a	decrease	 in	glucose	metabolism	was	ob-
served in the brain of animals subjected to ischemia and control diet 
as compared to sham- operated animals. This lack of sensitivity could 
be due to the limited resolution of the PET camera (ca. 1.7 mm at 
5 cm from the center of the field- of- view), which is in the same range 
as the size of the lesion, resulting in significant partial volume ef-
fects. Moreover, the location of the lesion might be slightly different 
between animals and consequently the effect of the small lesion on 
brain glucose metabolism will be averaged out over a larger region 
when group comparisons are made.
The main objective of this study was to investigate the effects 
of an investigational diet on symptoms observed following photo-
thrombotic	stroke.	A	disadvantage	of	the	photothrombotic	model	is	
that it causes permanent occlusion of the vessel. However, several 
studies have shown that anti- inflammatory treatment could cause 
a significant decrease in infarct size following photothrombotic 
stroke47 and improve behavioral outcome.48
The diet investigated in this study was designed to target neuroin-
flammation, as it contains elevated amounts of components, such as 
vitamins	A	and	D,	omega-	3	fatty	acids	and	specific	amino	acids	(tryp-
tophan), which all have been described to exert anti- inflammatory 
effects on immune cells in vitro and in vivo.6,7,20,49,50 The indigest-
ible galacto- oligosaccharides and fructooligosaccharides have been 
F IGURE  3  Infarct	size	on	day	7	A,	and	day	21	B,	after	focal	ischemia	induction.	The	infarct	size	was	assessed	on	the	isolated	brains	by	
measuring the length (alongside Bregma) and width (perpendicularly to Bregma) of the visible scar. Data are displayed as length*width in 
millimeters	for	animals	sacrificed	at	day	7	A,	and	day	21	B,	following	ischemia.	SC7, SC21 = stroke + control diet (n = 6, n = 5), SI- post7, SI- 
post21 = stroke + postischemic dietary intervention (n = 6, n = 5), SI- pre7, SI- pre21 = stroke + preischemic dietary intervention (n = 6, n = 6)
F IGURE  4 Cylinder test. To investigate the impact of ischemia and the investigational diet on asymmetric paw use, the cylinder test 
was performed. Rats were subjected to cylinder tests 1 week before the stroke induction or sham- surgery (baseline) and on days 3, 6 and 
20 following the ischemia or sham- surgery. The graphs represent the percentage usage of the left paw, contralateral to the stroke lesion. 
CC7, CC21 = control group (n = 6, n = 4), SC7, SC21 = stroke + control diet (n = 6, n = 5), SI- post7, SI- post21 = stroke + postischemic dietary 
intervention (n = 6, n = 5), SI- pre7, SI- pre21 = stroke + preischemic dietary intervention (n = 6, n = 6). CC = all control animals (12), SC = all 
surgery + control diet (n = 11), SI- pre = all stroke + preischemic dietary intervention (n = 12), SI- post = all stroke + postischemic dietary 
intervention (n = 11),. Significant differences between experimental groups and the CC7 group are indicated by **P < 0.01
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F IGURE  5 Astrocyte	activation:	Glial	
fibrillary	acidic	protein	(GFAP)	staining	
was performed to assess the effects 
of ischemia on astrocytes expression 
surrounding the lesion (SC vs CC) and 
the effect of the investigational diet 
thereon (SC vs SI- post and SC vs SI- pre). 
An	example	of	GFAP	staining	and	its	
quantification in the cortex surrounding 
the	stroke	lesion	on	day	7	(A)	and	at	
700 μm away from the lesion at day 7 
(B), surrounding the stroke lesion on 
day 21 (C) and at 700 μm away from the 
lesion	at	day	21	(D).	Astrocyte	activation	
was assessed by the area covered by 
GFAP	staining	in	the	region	of	interest.	
The data are displayed as the ratio 
between the lesion and the contralateral 
hemisphere, normalized to the values 
of the corresponding control group 
(CC7 or CC21). CC7, CC21 = control group 
(n = 6, n = 4), SC7, SC21 = stroke + control 
diet (n = 6, n = 5), SI- post7, SI- pre7, 
SI- pre21 = stroke + preischemic 
dietary intervention (n = 6, n = 6), SI- 
post21 = stroke + postischemic dietary 
intervention (n = 6, n = 5). Statistically 
significant differences are indicated as 
*P < 0.05, **P < 0.01, ***P < 0.001. For 
data analysis and illustration of the results, 
the colors on the white/black images have 
been inverted (white background)
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included in the investigational diet, because they have been shown 
to modulate the immune system via alteration of gut microbiota and 
by direct interaction with peripheral immune cells and thus could 
have an indirect effect on neuroinflammation via the gut- immune- 
brain axis.10
Body weight loss caused by the surgery (both sham and to induce 
stroke) was aggravated by the postischemic intervention with the in-
vestigational diet. This may be explained by the change of diet early 
directly	 after	 surgery	 in	 this	 group.	 Apparently,	 the	 animals	 need	
some time to get used to the new diet, as they hardly consumed 
little food in the first 2 days after the change of diet. Such an effect 
was also observed immediately after a change in diet in the groups 
subjected to preischemic diet intervention.
In the test performed in this investigation, we did not detect ben-
eficial effects of the investigational diets on the motor dysfunction, 
possibly because motor dysfunction was too transient and had al-
ready disappeared at day 6; furthermore, our are test we might not 
be sensitive enough to pick up more subtle changes in motor func-
tion. Dietary intervention also showed no significant effect on le-
sion size, probably due to the high variability between the size of the 
lesion between animals. On average, postischemia dietary interven-
tions seemed to reduce the growth of the ischemic lesion between 
day 7 and 21; however, this effect was not statistically significant.
Assessment	 of	 astrocyte	 expression	 revealed	 more	 persistent	
changes following stroke- induced ischemia, and these changes were 
modifiable by the diet. The 2 treatment regimens either prophylactic 
of therapeutic seemed to have interesting distinct spatiotemporal 
effects on astrocyte activation. The robust increase in astrocyte 
activation seen at 7 days after ischemia induction was further in-
creased by the investigational diet when started immediately after 
ischemia, but it was not affected by the investigational diet started 
2 weeks before the ischemia. On day 21, however, the postischemic 
dietary intervention caused complete reversal of the ischemia- 
induced astrocyte activation to control levels, while the preischemic 
dietary intervention caused only partial reversal of the astrocyte 
activation	 in	 the	 area	 close	 to	 the	 lesion.	Astrocytes	 are	 believed	
to act as double- edged sword, by being involved in both neurotoxic 
and neuroprotective mechanisms.51 It is believed that the early re-
sponse of astrocytes has a positive impact on recovery from stroke, 
while astrogliosis is detrimental for regeneration of the brain in later 
stages.23 The enhancement of the beneficial effect of astrocyte ac-
tivation in the early response to stroke and complete inhibition of 
detrimental effect at a later stage could indicate a positive effect of 
the postischemia diet.
[18F]FDG PET on day 7 demonstrated that preischemic dietary in-
tervention did not affect the glucose metabolism changes following 
ischemia. The postischemic dietary intervention caused an increase 
in brain glucose metabolism in somatosensory cortex ipsilateral to 
the lesion following cortical ischemia. This could be an indication of 
lower damage or increased metabolism in the tissue surrounding the 
lesion (due to the activation of immune cells involved in the damage 
repair or compensation mechanisms).
F IGURE  6 Brain glucose metabolism was measured with [18F]FDG positron emission tomography (PET) imaging to investigate whether 
stroke induction can lead to detectable changes in glucose metabolism (SC vs CC) and whether dietary intervention has an impact on 
glucose metabolism following stroke induction (SC vs SI- post and SC vs SI- pre). Differences in brain metabolism caused by ischemia and 
by	the	investigational	diet	in	animals	sacrificed	on	day	7.	(A)	[18F]FDG	standardized	uptake	values	(SUV)	uptake	in	the	whole	brain	(A,	B)	
and somatosensory cortex ipsilateral to the lesion (C, D) on day 7 and day 21 following ischemia. CC7, CC21 = control group (n = 6, n = 4), 
SC7, SC21 = stroke + control diet (n = 6, n = 5), SI- post7, SI- pre7, SI- pre21 = stroke + preischemic dietary intervention (n = 6, n = 6), SI- 
post21 = stroke + postischemic dietary intervention (n = 6, n = 5)
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In conclusion, we showed potential beneficial effects of a di-
etary intervention containing elevated amounts of specific anti- 
inflammatory nutrients on neuroinflammation following cortical 
ischemia.	 Although	 the	 cylinder	 test	 was	 not	 sensitive	 enough	 to	
detect effects of the intervention after a mild stroke (due to the low 
severity of the model and consequently transient effect on motor 
function), glucose measurement, a subtler assessment of brain func-
tion than the cylinder test, indicated that there were deficits in brain 
function, and that these were affected by the postischemic diet. 
Both post- and preischemic diet intervention modulated astrocyte 
activation. Taken together, these results warrant further investiga-
tion of postischemic dietary intervention as new therapeutic option 
for stroke.
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